Nyen JE, Booth AØ, Husby Ø, Bugge C, Engebretsen I, Oteiza F, Helland Å, Fjellbirkeland L, Brustugun OT, Grønberg BH(2025) Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study Front Oncol, 15, 1506041 DOI 10.3389/fonc.2025.1506041, PubMed 40052133
Brant SB, Børø S, Jonasson C, Helland Å, Thoresen S(2025) Comparative Effectiveness of First-Line Pembrolizumab vs. Chemotherapy in aNSCLC: A Norwegian Population-Based Cohort Study Clin Pharmacol Ther(in press) DOI 10.1002/cpt.3591, PubMed 39916352
Rakaee M, Tafavvoghi M, Ricciuti B, Alessi JV, Cortellini A, Citarella F, Nibid L, Perrone G, Adib E, Fulgenzi CAM, Hidalgo Filho CM, Di Federico A, Jabar F, Hashemi S, Houda I, Richardsen E, Rasmussen Busund LT, Donnem T, Bahce I, Pinato DJ, Helland Å, Sholl LM, Awad MM, Kwiatkowski DJ(2025) Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer JAMA Oncol, 11(2), 109-118 DOI 10.1001/jamaoncol.2024.5356, PubMed 39724105